KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Elevance Health (ELV) Accumulated Depreciation & Amortization (2016 - 2025)

Historic Accumulated Depreciation & Amortization for Elevance Health (ELV) over the last 17 years, with Q4 2025 value amounting to $4.1 billion.

  • Elevance Health's Accumulated Depreciation & Amortization rose 1030.73% to $4.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $4.1 billion, marking a year-over-year increase of 1030.73%. This contributed to the annual value of $4.1 billion for FY2025, which is 1030.73% up from last year.
  • According to the latest figures from Q4 2025, Elevance Health's Accumulated Depreciation & Amortization is $4.1 billion, which was up 1030.73% from $3.7 billion recorded in Q4 2024.
  • In the past 5 years, Elevance Health's Accumulated Depreciation & Amortization registered a high of $4.3 billion during Q4 2021, and its lowest value of $2.8 billion during Q4 2022.
  • In the last 5 years, Elevance Health's Accumulated Depreciation & Amortization had a median value of $3.7 billion in 2024 and averaged $3.7 billion.
  • As far as peak fluctuations go, Elevance Health's Accumulated Depreciation & Amortization crashed by 3541.47% in 2022, and later skyrocketed by 2643.6% in 2023.
  • Over the past 5 years, Elevance Health's Accumulated Depreciation & Amortization (Quarter) stood at $4.3 billion in 2021, then crashed by 35.41% to $2.8 billion in 2022, then increased by 26.44% to $3.5 billion in 2023, then increased by 3.75% to $3.7 billion in 2024, then grew by 10.31% to $4.1 billion in 2025.
  • Its last three reported values are $4.1 billion in Q4 2025, $3.7 billion for Q4 2024, and $3.5 billion during Q4 2023.